Precigen (PGEN) Other Operating Expenses (2012 - 2026)
Precigen's (PGEN) quarterly Other Operating Expenses came in at $2.6 million in Q1 2026, up 132.64% year-on-year from $1.1 million in Q1 2025, and up 60.34% on a QoQ basis from $1.6 million in Q4 2025.
Precigen (PGEN) Other Operating Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Other Operating Expenses data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 132.64% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $10.2 million, a 77.16% decrease from a year earlier, with the FY2025 full-year figure at $8.7 million, down 80.42% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2.6 million, up from $1.6 million in the prior quarter.
- Over the last five years, Other Operating Expenses for PGEN reached as high as $35.6 million in Q2 2024 and fell as low as $1.0 million in Q3 2024.
- Historically, Other Operating Expenses has averaged $4.7 million across 5 years, with a median of $1.6 million in 2025.
- Across the five-year window, Other Operating Expenses jumped 1995.4% in 2024 and sank 85.94% in 2025, its largest moves.
- Year by year, Other Operating Expenses stood at $1.3 million in 2022, then soared by 870.01% to $12.2 million in 2023, then tumbled by 43.02% to $6.9 million in 2024, then tumbled by 77.03% to $1.6 million in 2025, then surged by 60.34% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $2.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 35.56 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 1.89 Mn |